Amnion Life, LLC.
OVERVIEW

Amnion Life is a medical device company with a mission to develop and market novel devices to decrease mortality & complications in Preterm infants. AmniobedTM Golden Hour is the most advanced infant incubator in 100 years.

Amnion Life, LLC.
HYPOTHERMIA & PRETERM INFANTS

Today, a Premature Birth occurs Every Minute.

The Golden Hour

• Hypothermia Risk is the Most Significant in the First 60 minutes, Post Birth.
• Neonatology refers to the First 60 minutes Post-birth as the “Golden Hour”.

Hypothermic Consequences
Preterm Birth Infants often acquire Long-term Health Problems in their NICU stay.

Hypothermia in infants is associated with:

Brain Hemorrhage - Sepsis  Convulsions - Respiratory Distress - Anemia - Periventricular Leukomalacia - Apnea - Necrotizing Enterocolitis  -Meningitis - Bronchopulmonary Dysplasia - Death

In large European and NA studies, 50% of very preterm infants had hypothermia in the first 60 minutes after birth.

Pre -Term Infants Require

Amnion Life, LLC.
MOVING POSTNATAL CARE FORWARD

Amnion Life, LLC.
AMNIOBED EXPLAINED

Amniobe™ is the fluid filled incubator creating a warm and safe environment for growth and development of preterm infants.

Dialysis Grade Water Purification
Five medical grade water purification filters eliminate heavy metals, contaminants, and microorganisms from the hospital water. 

Amnion Life, LLC.
AMNIOBED™ PROTOTYPE VIDEO

Amnion Life, LLC.
TRACTION & ACCOMPLISHMENTS

AmnioBed Directed Patents

• US Patent No. 9,662,257, issued on May 30, 2017
• US Patent No. 10,166,161, issued on January 1, 2019
• China Patent No. 201680064293.7 issued January 8, 2020

Pending Foreign Patent Applications

• Europe, Japan, India, Australia, and Hong Kong

Press Mentions
November 12, 2018,  Pittsburgh Post-Gazette
​January 23, 2019, Seeking Alpha
October 24, 2019, Pharmacy and Therapeutics

Amnion Life, LLC.
MEET THE TEAM

​